ISTHMUS PARTNERS, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1639666 MADISON, WI

Position in HALO

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$385,905

-$66,552 QoQ

Shares Held

5,971

-11.2% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

ISTHMUS PARTNERS, LLC holds $8,691,901 across 5 Biotechnology names. HALO ranks #5 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	24,059	$4,803,379
2	MDXG	Mimedx Group, Inc.	482,127	$1,904,401
3	OABIW	OmniAb, Inc.	756,674	$1,187,978
4	JAZZ	Jazz Pharmaceuticals plc	2,170	$410,238
5	HALO	Halozyme Therapeutics, Inc. This page	5,971	$385,905

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$385,905	5,971	-11.2%	Shares	Sole	2026-04-30
2025-12-31	$452,457	6,723	-1.8%	Shares	Sole	2026-02-05
2025-09-30	$501,938	6,844	-0.5%	Shares	Sole	2025-11-10
2025-06-30	$357,637	6,875	0.0%	Shares	Sole	2025-08-13
2025-03-31	$438,693	6,875	+2.5%	Shares	Sole	2025-05-01
2024-12-31	$320,613	6,706	—	Shares	Sole	2025-02-07
No filing history on record for this holder in this stock.